Chang, H., Slamon, D., DeBruhl, N., Chap, L., Glaspy, J., Pegam, M., Lee, P., Malin, J., Chan, D., Barstis, J., Kass, F., Dichmann, R., Perkin, C., Villa, D., Ku, N., Kelley, A., Chung, D., David Geffen School of Medicine at UCLA and UCLA Oncology Network. A Phase II neoadjuvant study of Taxotere/Carboplatin/Herceptin (T/C/H) for locally advanced breast cancer: comparison of breast examination and imaging in assessing tumor response, 2004

Chang, H., Slamon, D., Chap L, Glaspy J, Pegam M, Lee P, Malin J, Chan D, Barstis J, Kass F, Dichmann R, Perkins, C., Villa, D., Ku, N., Kelley, A., Chung, D., David Geffen School of Medicine at University of California Los Angeles, and UCLA Oncology Network. A phase II neoadjuvant study of Taxotere, Carboplatin with or without Herceptin in locally advanced breast cancer: feasibility and toxicity, 2004

Villa, D. A Chief Resident’s Perspective in: The Ecology of Graduate Medical Education, 34-38. American Board of Medical Specialties, Evanston, IL, 1993

Goldschmidt, R.A., Merkel, D.E., Villa, D., Winchester, D.J., Fendelman, J., Gatbuton, C., Rademaker, A.W. Overaccumulation of P53 Protein and Tumor Diameter as Predictors of Recurrence for Patients with Node-Negative Infiltrating Ductal Carcinoma of the Breast. Abstract presented: Annual Meeting American Society of Clinical Oncology, 1994. Dallas, Texas